Managers / Q1 2019 · view latest →
Granite Point Capital Management, L.P.
CIK 0001599562 · 109 STATE STREET, 5TH FLOOR, BOSTON, MA, 02109 · 617-587-7507
Reported Value
$1.0B
Q1 2019
Positions
108
Filings on Record
19
2019–present window
Filed
May 14, 2019
original filing
Summary
Granite Point Capital Management, L.P. reported $1.0B in U.S.-listed holdings across 108 positions for Q1 2019.
Its largest position, Marinus Pharmaceuticals, represents 1.2% of the portfolio.
Portfolio Metrics
Top-10 Concentration
+6.5%
share of reported value
Largest Position
+1.2%
Marinus Pharmaceuticals
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- ETP · 55.2% · $571M
- Other · 20.9% · $216M
- Common Stock · 20.8% · $215M
- ADR · 2.5% · $26M
- US DOMESTIC · 0.5% · $6M
- NY Reg Shrs · 0.0% · $297,000
Quarter-over-Quarter Changes full breakdown →
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| IWMiShares Russell 2000 Index (ETF) | NEW | +1.68M | 1.68M | +$258M | $258M |
| PowerShares QQQ Trust, Series 1 (ETF) | NEW | +1.00M | 1.00M | +$180M | $180M |
| FXIISHARES TR | NEW | +2.01M | 2.01M | +$89M | $89M |
| SPYSPDR S&P 500 ETF TR | NEW | +175.0K | 175.0K | +$49M | $49M |
| SMHVANECK VECTORS ETF TR | NEW | +440.0K | 440.0K | +$47M | $47M |
| XBISPDR SERIES TRUST | NEW | +500.0K | 500.0K | +$45M | $45M |
| AAPLAPPLE INC | NEW | +200.0K | 200.0K | +$38M | $38M |
| SPDR SERIES TRUST | NEW | +1.00M | 1.00M | +$31M | $31M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2019
87 positions (from 88 filing rows — )
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | MARINUS PHARMACEUTICALS INC | COM | 1.23% | $13M | 3.05M |
| 2 | METAFACEBOOK INC | CL A | 0.91% | $9M | 56.3K |
| 3 | SIENTRA INC | COM | 0.73% | $8M | 880.0K |
| 4 | ZENDESK INC | COM | 0.65% | $7M | 79.2K |
| 5 | TILRAY INC | DEBT 5.000%10/0 | 0.56% | $6M | 7.00M |
| 6 | SESEA LTD | SPONSORED ADS | 0.52% | $5M | 230.0K |
| 7 | BOOTBOOT BARN HLDGS INC | COM | 0.50% | $5M | 175.0K |
| 8 | ZOGENIX INC | COM NEW | 0.46% | $5M | 86.6K |
| 9 | TNDMTANDEM DIABETES CARE INC | COM NEW | 0.46% | $5M | 75.0K |
| 10 | BILIBILIBILI INC | SPONS ADS REP Z | 0.45% | $5M | 245.0K |
| 11 | LULULULULEMON ATHLETICA INC | COM | 0.44% | $5M | 28.0K |
| 12 | AMZNAMAZON COM INC | COM | 0.43% | $4M | 2.5K |
| 13 | GOOGLALPHABET INC | CAP STK CL A | 0.40% | $4M | 3.5K |
| 14 | LITELUMENTUM HLDGS INC | NOTE 0.250% 3/1 · COM | 0.38% | $4M | 1.73M |
| 15 | EVERBRIDGE INC | COM | 0.35% | $4M | 48.0K |
| 16 | IMXIINTERNATIONAL MNY EXPRESS IN | COM | 0.34% | $3M | 300.0K |
| 17 | AXGNAXOGEN INC | COM | 0.33% | $3M | 160.9K |
| 18 | XENEXENON PHARMACEUTICALS INC | COM | 0.30% | $3M | 303.3K |
| 19 | GLNGGOLAR LNG LTD BERMUDA | SHS | 0.29% | $3M | 143.4K |
| 20 | AGSPLAYAGS INC | COM | 0.28% | $3M | 120.0K |
| 21 | YYEURYY INC | SPONSORED ADS A | 0.28% | $3M | 34.0K |
| 22 | GOOSCANADA GOOSE HOLDINGS INC | SHS SUB VTG | 0.26% | $3M | 55.0K |
| 23 | SRPTSAREPTA THERAPEUTICS INC | COM | 0.24% | $2M | 20.5K |
| 24 | JTUSDJIANPU TECHNOLOGY INC | ADR | 0.21% | $2M | 423.3K |
| 25 | CRESCENT ACQUISITION CORP | UNIT 99/99/9999 | 0.19% | $2M | 200.0K |
| 26 | AGXARGAN INC | COM | 0.19% | $2M | 40.0K |
| 27 | CDNACAREDX INC | COM | 0.19% | $2M | 61.2K |
| 28 | KRANESHARES TR | CSI CHI INTERNET | 0.18% | $2M | 39.7K |
| 29 | MATINAS BIOPHARMA HLDGS INC | COM | 0.18% | $2M | 1.71M |
| 30 | CARROLS RESTAURANT GROUP INC | COM | 0.17% | $2M | 178.0K |
| 31 | NOKNOKIA CORP | SPONSORED ADR | 0.17% | $2M | 300.0K |
| 32 | BABAALIBABA GROUP HLDG LTD | SPONSORED ADS | 0.16% | $2M | 9.0K |
| 33 | ADVANCED MICRO DEVICES INC | NOTE 2.125% 9/0 | 0.16% | $2M | 500.0K |
| 34 | BEASLEY BROADCAST GROUP INC | CL A | 0.16% | $2M | 408.5K |
| 35 | VIAVVIAVI SOLUTIONS INC | COM | 0.14% | $1M | 113.2K |
| 36 | AXOVANT SCIENCES LTD | COM | 0.13% | $1M | 1.03M |
| 37 | PDDPINDUODUO INC | SPONSORED ADS | 0.13% | $1M | 55.0K |
| 38 | ELECTROCORE INC | COM | 0.12% | $1M | 178.6K |
| 39 | ONON SEMICONDUCTOR CORP | COM | 0.12% | $1M | 60.0K |
| 40 | ARRAY BIOPHARMA INC | COM | 0.12% | $1M | 50.0K |
| 41 | QUOTIENT LTD | SHS | 0.12% | $1M | 135.0K |
| 42 | CQQQINVESCO EXCHNG TRADED FD TR | CHINA TECHNLGY | 0.11% | $1M | 22.6K |
| 43 | EGANEGAIN CORP | COM NEW | 0.10% | $1M | 102.8K |
| 44 | NEW ORIENTAL ED & TECH GRP I | SPON ADR | 0.10% | $991,000 | 11.0K |
| 45 | FINISAR CORP | NOTE 0.500%12/1 | 0.10% | $982,000 | 1.00M |
| 46 | BMYBRISTOL MYERS SQUIBB CO | COM | 0.09% | $954,000 | 20.0K |
| 47 | RNGRINGCENTRAL INC | CL A | 0.09% | $919,000 | 8.5K |
| 48 | NOODLES & CO | COM CL A | 0.09% | $917,000 | 134.9K |
| 49 | AERIE PHARMACEUTICALS INC | COM | 0.09% | $884,000 | 18.6K |
| 50 | VFFVILLAGE FARMS INTL INC | COM | 0.08% | $841,000 | 60.0K |
| 51 | INNOVATE BIOPHARMACEUTICLS I | COM PAR | 0.08% | $828,000 | 429.2K |
| 52 | CTRIP COM INTL LTD | SPONSORED ADS | 0.08% | $812,000 | 18.6K |
| 53 | NEOPHOTONICS CORP | COM | 0.07% | $775,000 | 123.2K |
| 54 | OPIANT PHARMACEUTICALS INC | COM | 0.07% | $761,000 | 58.0K |
| 55 | YRDYIRENDAI LTD | SPONSORED ADR | 0.07% | $760,000 | 56.0K |
| 56 | DIREXION SHS ETF TR | CSI 300 BULL2X | 0.07% | $746,000 | 31.0K |
| 57 | OVIDOVID THERAPEUTICS INC | COM | 0.07% | $740,000 | 417.9K |
| 58 | RUBIUS THERAPEUTICS INC | COM | 0.06% | $667,000 | 36.8K |
| 59 | 58 COM INC | SPON ADR REP A | 0.06% | $663,000 | 10.1K |
| 60 | BIDUBAIDU INC | SPON ADR REP A | 0.06% | $659,000 | 4.0K |
| 61 | MPAAMOTORCAR PTS AMER INC | COM | 0.06% | $610,000 | 32.3K |
| 62 | EYEPOINT PHARMACEUTICALS INC | COM | 0.06% | $589,000 | 329.0K |
| 63 | MAGNACHIP SEMICONDUCTOR SA | NOTE 5.000% 3/0 | 0.05% | $567,000 | 500.0K |
| 64 | VIPSVIPSHOP HLDGS LTD | SPONSORED ADS A | 0.05% | $562,000 | 70.0K |
| 65 | ESTAESTABLISHMENT LABS HLDGS INC | COM | 0.05% | $543,000 | 22.6K |
| 66 | ATHENEX INC | COM | 0.05% | $490,000 | 40.0K |
| 67 | NTESNETEASE INC | SPONSORED ADR | 0.05% | $483,000 | 2.0K |
| 68 | BBBYOVERSTOCK COM INC DEL | COM | 0.04% | $456,000 | 27.4K |
| 69 | FXIISHARES TR | CHINA LG-CAP ETF | 0.04% | $443,000 | 10.0K |
| 70 | LXLEXINFINTECH HLDGS LTD | ADR | 0.04% | $420,000 | 40.0K |
| 71 | TYLTYLER TECHNOLOGIES INC | COM | 0.04% | $409,000 | 2.0K |
| 72 | ADAMAS PHARMACEUTICALS INC | COM | 0.04% | $390,000 | 54.8K |
| 73 | XILINX INC | COM | 0.04% | $380,000 | 3.0K |
| 74 | ARLOARLO TECHNOLOGIES INC | COM | 0.04% | $366,000 | 88.6K |
| 75 | CHANGYOU COM LTD | ADS REP CL A | 0.03% | $349,000 | 20.4K |
| 76 | GLOBAL EAGLE ENTMT INC | NOTE 2.750% 2/1 | 0.03% | $322,000 | 500.0K |
| 77 | TALTAL EDUCATION GROUP | SPONSORED ADS | 0.03% | $318,000 | 8.8K |
| 78 | AOSLALPHA & OMEGA SEMICONDUCTOR | SHS | 0.03% | $310,000 | 26.9K |
| 79 | UXIN LTD | ADS | 0.03% | $303,000 | 80.0K |
| 80 | STMSTMICROELECTRONICS N V | NY REGISTRY | 0.03% | $297,000 | 20.0K |
| 81 | CHINACACHE INTL HLDG LTD | SPONSORED ADR | 0.02% | $234,000 | 187.5K |
| 82 | TMETENCENT MUSIC ENTMT GROUP | SPON ADS | 0.02% | $210,000 | 11.6K |
| 83 | BRIGHT SCHOLAR ED HLDGS LTD | SPONSORED ADS | 0.02% | $207,000 | 20.0K |
| 84 | FANG HLDGS LTD | ADR | 0.02% | $166,000 | 123.0K |
| 85 | ACMRACM RESEARCH INC | COM CL A | 0.02% | $158,000 | 10.2K |
| 86 | HTTQUDIAN INC | ADR | 0.01% | $152,000 | 30.0K |
| 87 | SEMICONDUCTOR MFG INTL CORP | SPONSORED ADR | 0.01% | $123,000 | 24.3K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2023 | $0 | 1 | Nov 7, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | Under review | 1 | Aug 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $72M | 52 | May 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $157M | 90 | Feb 7, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $247M | 103 | Nov 4, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $392M | 108 | Aug 5, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $479M | 125 | May 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $590M | 127 | Feb 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $1.3B | 182 | Nov 10, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $2.7B | 212 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $2.7B | 254 | May 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $1.9B | 150 | Feb 5, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $1.8B | 164 | Nov 6, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $2.0B | 140 | Aug 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $177M | 72 | May 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $641M | 88 | Feb 10, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $639M | 68 | Oct 30, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $1.5B | 88 | Jul 29, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $1.0B | 108 | May 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.